Hidden Killers: Human Fungal Infections

  title={Hidden Killers: Human Fungal Infections},
  author={Gordon D. Brown and David W. Denning and Neil A. R. Gow and Stuart M. Levitz and Mihai G. Netea and Theodore C. White},
  journal={Science Translational Medicine},
  pages={165rv13 - 165rv13}
The lack of robust rapid diagnostic tests, safe and effective drugs, and preventative vaccines hampers treatment of patients with invasive fungal infections. Although fungal infections contribute substantially to human morbidity and mortality, the impact of these diseases on human health is not widely appreciated. Moreover, despite the urgent need for efficient diagnostic tests and safe and effective new drugs and vaccines, research into the pathophysiology of human fungal infections lags… 

Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal Diseases

The potential anti-fungal targets for patient-centered therapies and immune-enhancing strategies for the prevention and treatment of invasive fungal diseases are reviewed.

Innate Defense against Fungal Pathogens.

This review will outline the cells and PRRs required for effective antifungal immunity, with a special focus on the major antIFungal cytokine IL-17 and recently characterized antifunkal inflammasomes.

Immunotherapy for Fungal Infections

This chapter is intended to review advances in immunotherapy strategies for fungal infections and suggests novel therapeutic approaches are welcome to stimulate efficiently the host immune response to eliminate the fungal pathogen.

Pathogenesis of Fungal Infections

The following discussion intends to highlight the pathogenesis of fungal infections with special reference to central nervous system in humans.

13 Functional Genomics to Characterize Opportunistic Pathogens

Knowledge of the DNA sequence of microorganisms and the application of functional genomics is a promising tool to understand the interplay between pathogens and host cells and to improve diagnosis, identify new drug targets, and develop tailor-made drugs.

Human fungal pathogens: Why should we learn?

Eleven review articles concerning the virulence mechanisms and host interactions of four major human fungal pathogens–Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, and Histoplasma capsulatum–are presented in this special issue.

Immune defence to invasive fungal infections: A comprehensive review.

Immunotherapeutic approaches for fungal infections.

Immunotherapeutic approaches to treatment of fungal diseases.

Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies

The global burden of fungal infections, the reservoirs of these pathogens, the traits of opportunistic yeast that lead to pathogenesis, host genetic susceptibilities, and the challenges that must be overcome to combat antifungal drug resistance and improve clinical outcome are reviewed.



Fungal vaccines: real progress from real challenges.

  • A. Cassone
  • Biology
    The Lancet. Infectious diseases
  • 2008

Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box

Cryptococcus neoformans is generally considered to be an opportunistic fungal pathogen because of its tendency to infect immunocompromised individuals, particularly those infected with HIV. However,

An insight into the antifungal pipeline: selected new molecules and beyond

This Review focuses on recent developments in the antifungal pipeline, concentrating on promising candidates such as new azoles, polyenes and echinocandins, as well as agents such as nikkomycin Z and the sordarins.

Antifungal agents: mechanisms of action.

The epidemiology of histoplasmosis: a review.

The epidemiologic and ecologic features of histoplasmosis are described, highlighting the implications for prevention and development of better diagnostic tests for detection of disease in humans and of the organism in the environment.

Colonization by Pneumocystis jirovecii and Its Role in Disease

The immune response is critical in preventing this disease but also results in lung damage, and future work may offer potential areas for vaccine development or immunomodulatory therapy.

Exciting developments in the immunology of fungal infections.

Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

It is raised the possibility that iron chelator therapy may be useful to treat the infection as long as the chelator does not inappropriately supply the fungus with iron.

Emerging fungal threats to animal, plant and ecosystem health

It is argued that nascent fungal infections will cause increasing attrition of biodiversity, with wider implications for human and ecosystem health, unless steps are taken to tighten biosecurity worldwide.